Xiangjiao J. Meng

Jinan, 250014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Comparison of antibody persistence after two-dose and three-dose hepatitis B vaccines for 20 years among people aged 15-40 years in Shandong Province

Comparison of antibody persistence after two-dose and three-dose hepatitis B vaccines for 20 years among people aged 15-40 years in Shandong Province

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: August 13, 2026

AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

Journal: Journal for immunotherapy of cancer

Published: July 28, 2026

Epidemiological and genetic characteristics of hepatitis E virus in Yantai City and Weihai City, Shandong Province from 2021 to 2024

Epidemiological and genetic characteristics of hepatitis E virus in Yantai City and Weihai City, Shandong Province from 2021 to 2024

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: July 27, 2026

Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.

Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.

Journal: Future oncology (London, England)

Published: June 03, 2026

Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP).

Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP).

Journal: Clinical & experimental metastasis

Published: May 29, 2026

Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study.

Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study.

Journal: Cancer biology & medicine

Published: May 12, 2026

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.

Journal: Lancet (London, England)

Published: April 23, 2026

Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer.

Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer.

Journal: Cancer biology & medicine

Published: April 22, 2026

Analysis of trends in the disease burden of hepatitis A and hepatitis E in China from 1990 to 2021

Analysis of trends in the disease burden of hepatitis A and hepatitis E in China from 1990 to 2021

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: April 16, 2026

Target-triggered assembly of engineered bacteria enables dual-mode detection of microRNA.

Target-triggered assembly of engineered bacteria enables dual-mode detection of microRNA.

Journal: Biosensors & bioelectronics

Published: April 08, 2026

Treatment patterns and outcomes of later-line therapy in advanced non-small cell lung cancer with unknown or no actionable genomic alterations: a multicenter real-world study in China (RECAP study).

Treatment patterns and outcomes of later-line therapy in advanced non-small cell lung cancer with unknown or no actionable genomic alterations: a multicenter real-world study in China (RECAP study).

Journal: Translational lung cancer research

Published: March 30, 2026

Longitudinal DCE MRI Vascular Textures: Radiologic and Biologic Insights for pCR Prediction in HER2-Negative Breast Cancer.

Longitudinal DCE MRI Vascular Textures: Radiologic and Biologic Insights for pCR Prediction in HER2-Negative Breast Cancer.

Journal: Radiology. Artificial intelligence

Published: March 25, 2026

Showing 1-12 of 144

Last Updated: 09/26/2026